SBIO
Fund Stats as of 12/12/2018
Symbol SBIO
CUSIP 00162Q 593
ISIN US00162Q5936
Inception Date 12/30/2014
Dividends Paid Annual
Fund Type Exchange Traded Fund
Market Price $32.37
Last Trade Price $32.35
NAV $32.40
NAV Change $0.53
Total Net Assets $210,617,091
Total Market Value $210,025,175
Premium/Discount(%) -0.09%
Difference ($) $-0.03
Volume 33,361
Shares Outstanding 6,500,000
Expenses as of 03/31/2018
Management Fee0.50%
Other Expenses0.00%
Total Operating Expenses0.50%
Fund Resources
Summary Prospectus 
Statement of Additional Information 
Quarterly Fact Sheet 
Statutory Prospectus 
Resource Library  

Index Characteristics as of 9/30/2018, subject to change

Index Top Ten Holdings

Index Name % of Index
Ligand Pharmaceutical 3.57%
Galapagos Nv-Spon Adr 3.56%
United Therapeutics Co 3.43%
Loxo Oncology Inc 3.21%
Fibrogen Inc 3.16%
Gw Pharmaceuticals -A 3.02%
Amarin Corp Plc -Adr 2.94%
Agios Pharmaceuticals 2.76%
Hutchison China Medite 2.64%
Taro Pharmaceutical In 2.39%

PMBI Drug Development Pipeline

Pre-Clinical 466
Phase I 382
Phase II 498
Phase III 163
Regulatory Filing for Approval 24
Other 49

Index Profile

Index Description Value
Number of Companies 111
Company Size ($ Millions)
   Average $2,977
   Median $776
   Largest $6,143
   Smallest $68
Weight of Top 10 30.68%
Large cap (>$10bn) 0.0%
Mid cap ($2-10bn) 67.14%
Small cap (<$2bn) 32.86%